ÐÂÎŶ¯Ì¬
²®¼ªË¹ÊÔ¼Á¼ò½é
²®¼ªË¹ÊÔ¼Á£¨BurgessÊÔ¼Á£©£¬¼´N-(ÈýÒÒ»ù°±»Çõ£)°±»ù¼×Ëá¼×õ¥£¬ÊÇÒ»ÖÖ°±»ù¼×Ëáõ¥ÀàµÄÄÚÑΣ¬»¯Ñ§Ê½ÎªC8H18N2O4S£¬½á¹¹Ê½ÈçͼËùʾ£¬·Ö×ÓÁ¿Îª238.3£¬Íâ¹ÛΪÀà°×É«·Ûĩ״¹ÌÌå¡£¸Ã²úÆ·¹ØÓÚ¿ÕÆøºÍʪ¶ÈÊ®·ÖÃô¸Ð£¬ÈÝÒ×Ñõ»¯£¬Ó¦µÍøÉúÑÄ£¬²¢ÇÒ¾¡¿ìʹÓá£ÔÚÓлúºÏ³ÉÖУ¬Ëü¿ÉÈÜÓÚ´ó´ó¶¼ÓлúÈܼÁ£¬ÊÇÒ»ÖÖ¸ßЧµÄÍÑË®¼Á¡£BurgessÊÔ¼Á¿ÉÒÔºÜÊǸßЧµÄ½«ÖÙ´¼ºÍÊå´¼ÍÑË®ÖÆ±¸Ï©Ìþ£¬¸Ã·´Ó¦¾ßÓÐ˳λѡÔñÐÔ£¬Í¨³£ÊÇÖÙ´¼µÄÑ¡ÔñÐÔ¸ü¸ß¡£Êå´¼ÔòÔÚÔ½·¢ÎÂ˳µÄÌõ¼þÏ£¬¿ìËÙÐγÉÎȹ̵ÄÈý¼¶Ì¼ÕýÀë×Ó£¬»ñµÃE1Ïû³ýµÄ²úÆ·¡£Ò»¼¶´¼·´Ó¦Ð§¹û²»¼Ñ£¬ÍùÍùÊÇת»¯³ÉÏìÓ¦µÄ°±»ù¼×Ëáõ¥£¬ÔÙ±¬·¢Ë®½âÌìÉú²®°·À໯ºÏÎï¡£ÔÚ20ÊÀ¼Í80ÄêÔºó°ëÆÚ£¬BurgessÊÔ¼ÁÒ²±»ÓÃÓÚÔÚÊÒÎÂϽ«²®°·ºÍë¿ÍÑË®³ÉÏìÓ¦µÄëæ£»¼×õ£°·»ñµÃÒìëæ£¬ÄòËØ×ª»¯³É̼¶þõ£Ñǰ·£¬²®Ïõ»ùÍéÌþÔÚ²®¼ªË¹ÊÔ¼Á´¦Öóͷ£ºó±¬·¢Ñõ»¯ëæ¡£
½üÄêÀ´£¬BurgessÊÔ¼ÁµÄ×î´óÓÃ;ÊÇʵÏÖôÇ»ùõ£°·ºÍÁòõ£°·µÄ»·»¯ÍÑÇâ·´Ó¦£¬»ñµÃÏìÓ¦µÄÔÓ»·»¯ºÏÎï¡£
ͨʽ
ʵÀý
²®¼ªË¹ÊÔ¼ÁÓë´¼µÄ·´Ó¦
¶þ¼¶´¼ÒÔ¼°Èý¼¶´¼£¬ÔÚ·ÇÖÊ×ÓÈܼÁÖУ¬ÎÂ˳µÄÌõ¼þÏ»ñµÃÏìÓ¦µÄÏ©Ìþ¡£²¢ÇÒ£¬ÔÚ²®¼ªË¹ÊÔ¼Á¼ÓÈëµÄÍÑË®³ÉÏ©ÌþÀú³ÌÖУ¬Ô½·¢ÓÐÀûµØÌìÉúÔúÒÁ²É·òÏ©Ìþ¡£
·Ö×ÓÄÚÁ½·Ö×ÓÁò´¼ÍÑË®»ñµÃÁòÃÑÀà²úÆ·¡£
Bielawski¿ÎÌâ×黹±¨µÀÁËÔÚDMSOÏûÈÚÏ£¬¶þ¼¶´¼¿ÉÒÔÓë²®¼ªË¹ÊÔ¼Á·´Ó¦»ñµÃÏìÓ¦µÄͪÀ໯ºÏÎ²¢ÇÒÔÚÈýÒÒ°·Ñλù´¡ÉÏ£¬¿ª·¢Á˲î±ðï§ÑεIJ®¼ªË¹ÊÔ¼Á¡£
Ò»¼¶´¼¿ÉÒÔÓë²®¼ªË¹ÊÔ¼Á»ñµÃÏìÓ¦µÄ°±»ù¼×Ëáõ¥¡£
²®¼ªË¹ÊÔ¼ÁÓë°±»ùµÄ·´Ó¦
µ±µ×Îï¾ßÓÐÃô¸Ð²»Îȹ̵ĻùÍÅʱ£¬õ£°·×ª»»³ÉëæÀ໯ºÏÎïÍùÍùÐèÒªÌáǰ¶ÔÕâЩ»ùÍžÙÐб£»¤£»¶ø²®¼ªË¹ÊÔ¼ÁÔò¿ÉÒÔÔÚºÜÎÂ˳µÄÌõ¼þÏ£¬²»ÐèÒªÌØÁíÍâ±£»¤£¬Ò»²½¸ßЧ»ñµÃת»»µÄ²úÆ·¡£
ÀýÈ磬µ±µ×ÎïÖк¬ÓÐôÇ»ù£¬ÈýÔªÑõÔÓ»·£¬Boc±£»¤»ùµÈ£¬²®¼ªË¹ÊÔ¼Á¾ù¿ÉÒÔ¸ßÑ¡ÔñÐÔÓëõ£°··´Ó¦»ñµÃëæ¡£
²®¼ªË¹ÊÔ¼ÁÓë¼×õ£°·³ÉÒìëæ
²®¼ªË¹ÊÔ¼ÁÓëëåÐγÉÑǰ·
²®¼ªË¹·Ö×ÓÄÚÐγÉÔÓ»·
ÔÚàçßòßøÓë°±»ùËáC-2ÏàÁ¬µÄÊÖÐÔÖÐÐĺÜÈÝÒ×±¬·¢²îÏòÒì¹¹»¯£¬ÒÔÖÁÓÚ´ó´ó¶¼ôÇ»ùÁòõ£°·µÄ»·»¯ÍÑË®·´Ó¦¶¼»áÌìÉú·Ç¶ÔÓ³Òì¹¹Ìå»ìÏýÎȻ¶øÔÚBurgess ÊÔ¼ÁµÄÓÕµ¼Ï£¬ôÇ»ùÁòõ£°·»á¸ßÁ¢ÌåÑ¡ÔñÐԵػñµÃ96%²úÂʺʹóÓÚ94%¶ÔӦѡÔñÐÔµÄÊÖÐÔµ¥Ìå¡£
ÔÚ²®¼ªË¹ÊÔ¼ÁµÄÓÕµ¼Ï£¬ôÇ»ùÁòõ£°·Äܹ»¸ß²úÂʵØ×ª»¯Îªàçຣ¬ÕâÒ»ÒªÁì±ÈMitusnobu·´Ó¦ÄÜ»ñµÃ¸ü¸ßµÄ²úÂÊ¡£
ÎÄÏ×µ÷Ñл¹·¢Ã÷£¬²®¼ªË¹ÊÔ¼Á¿ÉÒÔÓë¶à¾ÛÒÒ¶þ´¼ÅþÁ¬£¬»ñµÃÒ»ÖÖÔ½·¢Îȹ̣¬ÍÑˮЧÂʸü¸ßµÄ¾ÛºÏÎïPEG-linked burgess reagent¡£
²»¾Ãǰ£¬»ÔÈð¹«Ë¾¸Õ»ñÅúÉÏÊÐÁËÒ»¿î¹ØÓÚ¿¹»÷йÚÒßÇéºÅ³Æ¿ÉÒÔÅ¤×ªÊ±ÊÆ£¨a game-changer£©µÄ¿Ú·þÒ©Îï-Paxlovid¡£PaxlovidÊÇ3CLÂѰ×øÒÖÖÆ¼ÁPF-07321332ÓëµÍ¼ÁÁ¿ÀûÍÐÄÇΤ(Ritonavir)µÄ¸´·½ÖƼÁ£¬ÈýÆÚÁÙ´²Ð§¹ûÊý¾ÝÅú×¢£¬ÇáÖжÈйڻ¼ÕßÔÚÈ·ÕïÈýÌìÄÚ·þÓøÃÒ©£¬×¡Ôº»òéæÃüΣº¦¿É½µµÍÔ¼89%¡£¶ø²®¼ªË¹ÊÔ¼ÁÔÚPaxlovidÒ©ÎïµÄºÏ³ÉÑо¿ÖÐÆðµ½ÁËÖÁ¹ØÖ÷ÒªµÄ×÷Óá£
²Î¿¼ÎÄÏ×£º
1. Mal, D.; Khapli, S.; Dey, S. J. Indian Inst. Sci., July-Aug. 2001, 81, 461-476.
2. Bielawski, C. W.; Sultane, P. R. J. Org. Chem. 2017, 82, 1046-1052.
3. Hudlicky, T.; Banfield, S. C. J. Org. Chem. 2007, 72, 13, 4989¨C4992.
4. Yasukata, T.; Maki, T.; Tsuritani T. Org. Lett. 2014, 16, 7, 1868¨C1871.
5. Burgess, E. M.; Penton, H. R., Jr.; Taylor, E. A.; Williams, W. M. Org. Synth. Coll. Edn. 1987, 6, 788¨C791.
6. Duncan, J. A.; Hendricks, R. T.; Kwong, K. S. J. Am.Chem. Soc. 1990, 112, 8433¨C8442.
7. Smith, A. B. J. Am. Chem. Soc. 2003, 125, 8228.
8. Ven, S.; Wipf, P. Tetrahedron Lett. 1994, 35, 5397.
9. Fritch, P.; Wipf, p. Tetrahedron Lett. 1996, 37, 4659.
10. https://www.nytimes.com/2021/11/05/health/pfizer-covid-pill.html.